NCT00311441View on ClinicalTrials.gov

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

March 31, 2005

Conditions

Encephalitis, Tick-Borne

Interventions

BIOLOGICAL

Tick-Borne Encephalitis vaccine

Trial Locations (1)

Unknown

Weilheim

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Vaccines

All Listed Sponsors

collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY